Engineered probiotic heads to human trials (opens in new tab)

A probiotic bioengineered by UBC Okanagan researchers to thrive in the inflamed gut is set to enter human clinical trials in Australia this summer, capping a decade-long effort to turn a beneficial bacterium into a treatment for inflammatory bowel disease.